查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618294

電子處方的全球市場的評估:各產品，給藥方式，各終端用戶，各地區，機會，預測(2018年～2032年)

E-Prescribing Market Assessment, By Product [Solutions, Services], By Delivery Mode [Web/Cloud-Based, On-Premises], By End-user [Hospitals, Pharmacies, Office-Based Physicians], By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 244 Pages | 商品交期: 3-5個工作天內

價格

全球電子處方市場規模預計將從 2024 年的 39.3 億美元增至 2032 年的 239.5 億美元，預計 2025-2032 年的複合年增長率為 25.35%。由於擴大採用數位醫療保健解決方案並專注於最大限度地降低醫療保健成本，預計市場在預測期內將出現強勁增長。

電子處方已成為提高病患照護品質的關鍵要素，它允許醫生從 Masu 直接以電子方式發送準確、無錯誤且易於理解的處方。市場成長的主要驅動力是政府推廣電子健康記錄（EHR）和電子處方系統的舉措，特別是在發達地區，以及慢性病患病率的增加以及醫療保健專業人員有效開處方的需求不斷增加。尋找管理系統。這些節省成本的優勢，以及簡化醫療保健工作流程的日益增長的需求，使電子處方成為對醫療保健提供者和組織有吸引力的解決方案。產品的推出和市場的擴張進一步推動了市場的成長。例如，2023 年 11 月，阿斯特捷利康公司推出了數位健康解決方案提供者 Evinova，以加強臨床試驗和病患照護。 Evinova 在阿斯特捷利康的支持下，與 Parexel International (MA) Corporation 和 Fortrea Inc. 合作，專注於利用成熟的數位技術優化藥物開發，並正在規劃擴展到遠端患者監測和數位治療領域。

本報告提供全球電子處方市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球電子處方市場預測(2018年～2032年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各給藥方式
    • 各終端用戶
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2024年)
  • 市場地圖分析(2024年)
    • 各產品
    • 各給藥方式
    • 各終端用戶
    • 各地區

第5章 北美的電子處方市場預測(2018年～2032年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各給藥方式
    • 各終端用戶
    • 佔有率:各國
  • 各國的市場評估
    • 美國的電子處方市場預測(2018年～2032年)
    • 加拿大
    • 墨西哥

第6章 歐洲的電子處方市場預測(2018年～2032年)

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章 亞太地區的電子處方市場預測(2018年～2032年)

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 印尼
  • 菲律賓

第8章 南美的電子處方市場預測(2018年～2032年)

  • 巴西
  • 阿根廷

第9章 中東·非洲的電子處方市場預測(2018年～2032年)

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第10章 供需分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 大環境分析

第14章 價格分析

第15章 市場動態

  • 推動市場要素
  • 市場課題

第16章 市場趨勢與發展

第17章 法規結構和革新

  • 法規當局的認證
  • 革新

第18章 專利形勢

第19章 案例研究

第20章 競爭情形

  • 前五名市場領導者的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大主要企業的形勢
    • Practice Fusion, Inc.
    • McKesson Corporation
    • Networking Technology, Inc. dba RXNT
    • Athenahealth, Inc.
    • EMDs, Inc. (CopuGroup Medical, Inc.)
    • Cerner Corporation
    • UnitedHealth Group
    • Epic Systems Corporation
    • NextGen Healthcare, Inc.
    • DrFirst.com, Inc.

第21章 策略性推薦

第22章 本公司相關資料，免責聲明

Product Code: MX12444

Global e-prescribing market is projected to witness a CAGR of 25.35% during the forecast period 2025-2032, growing from USD 3.93 billion in 2024 to USD 23.95 billion in 2032. The global e-prescribing market is expected to grow robustly during the forecast period owing to the increasing adoption of digital healthcare solutions and the rising focus on minimizing healthcare costs.

E-prescribing enables physicians to transmit accurate, error-free, and easy-to-understand prescriptions electronically from the point of care directly to pharmacies and is a key element in improving the quality of patient care. Key factors driving the market growth include government initiatives promoting electronic health records (EHR) and e-prescribing systems, especially in developed regions, and the increasing prevalence of chronic diseases, which are pushing healthcare providers towards efficient prescription management systems. These cost-containment benefits, along with the growing need to streamline healthcare workflow, have made e-prescribing an attractive solution for healthcare providers and organizations. Product launch and market expansion further fuel the market growth. For instance, in November 2023, AstraZeneca plc launched Evinova, a digital health solutions provider, to enhance clinical trials and patient care. Backed by AstraZeneca and in collaboration with Parexel International (MA) Corporation and Fortrea Inc., Evinova focuses on optimizing drug development through established digital technologies, with plans to expand into remote patient monitoring and digital therapeutics.

Increased Focus on Cost Reduction Boosts Market Growth

Increasing focus on cost reduction for healthcare is a growth driver for the e-prescription market as healthcare organizations continue to look for ways to streamline operations and reduce financial burden while still providing quality patient care. E-prescription systems significantly reduce costs by minimizing the time and resources required to manage prescriptions, thus reducing administrative costs. In addition, e-prescription contributes to more efficient inventory management as a medical service provider can avoid unnecessary drug waste, further reducing operating costs. Fuel the market growth. For instance, in July 2024, Commure, Inc. acquired Augmedix, Inc., for USD 139 million to enhance AI-driven clinical documentation and revenue cycle automation. Augmedix, Inc., will become a subsidiary of Commure, Inc., allowing the companies to scale their solutions and improve clinician productivity across health systems. The combined technologies aim to support over three million physician appointments this year.

Technological Advancements in Healthcare-IT and Digital Health

Technological advancements in the healthcare IT and digital health sectors are primarily driving the growth of the e-prescription market. Advanced technologies with cloud platforms, artificial intelligence, and machine learning have substantially enhanced the capabilities and efficiency of systems for e-prescribing. These innovations make prescribing easier and allow live access to and management of prescription information from nearly anywhere. In addition, cloud-based e-prescribing solutions offer a cost-effective, easy-to-deploy platform, even for smaller practices, while AI and machine learning enable more advanced capabilities, such as predictive analytics on patient medication adherence and drug interaction alerts. For instance, in December 2023, DrFirst.com, Inc. launched iPrescribe Connect, a new feature that enhances communication for prescribers while maintaining privacy. This tool allows prescribers to contact patients using their personal mobile phones without revealing personal information, displaying a customizable office number instead. iPrescribe Connect, included with every paid subscription, uses caller ID masking technology to improve patient recognition and response rates, offering flexibility for prescribers to work on the go.

Web/Cloud-Based Segment to Dominate the E-Prescribing Market

The web/cloud-based segment is expected to dominate the e-prescribing market, primarily due to its high-cost efficiency, scalability, and flexibility in deployment. Cloud-based e-prescribing systems do not require high investments in IT infrastructure and hardware. This attracts healthcare facilities of all sizes, especially smaller clinics and independent practices. Healthcare providers can access prescription data securely from anywhere, which enhances the possibility of remote care and real-time decision-making. Integrating electronic health records and other healthcare applications is also easier with cloud-based platforms. The web/cloud-based segment is expected to lead the market as the healthcare industry's attention shifts towards digital, flexible, and cost-effective solutions. For instance, in March 2022, First Databank, Inc. launched FDB Vela, a cloud-native ePrescribing network designed to streamline the flow of medication information, benefits verification, and clinical decision support among prescribers, payers, pharmacies, and other stakeholders. The platform provides non-exclusive transaction services, helping participants enhance value for their customers and patients through improved prescribing and fulfillment processes.

North America Dominates the E-Prescribing Market

North America is likely to be one of the prominent regions in the global market for e-prescribing, led primarily by its well-developed infrastructure in healthcare, high adoption rates of advanced healthcare IT solutions, and a supportive regulatory environment. Such widespread adoption of e-prescribing systems through the high priority laid by the region in reducing medication errors and improving patient safety in the United States, especially, has been accelerated through federal mandates and incentives under programs like the Health Information Technology for Economic and Clinical Health (HITECH) Act. For instance, in October 2024, Tarrant Capital IP, LLC acquired a majority stake in Surescripts, LLC to drive further investment in its e-prescribing technology and explore M&A opportunities. The deal strengthens Surescripts, LLC's position as a leader in electronic healthcare transactions, connecting over 2 million healthcare professionals and covering 99% of the United States population.

Future Market Scenario (2024-2031F)

The global e-prescribing market is expected to seem very promising in the forecast period, as it is being driven by continuous and progressive healthcare technology advancements, increased demand for efficient and error-free medication management, and ever-growing adoption in both developed and emerging markets. E-prescribing systems will probably remain a key element of the digital health strategy for healthcare providers worldwide to focus on quality and efficiency in patient care. Improved integration with AI and machine learning might increase functionalities involving predictive analytics related to patient adherence, personalized advice on medication, and improved alert systems regarding interactions of drugs. Market expansion is expected to increase with more emerging cloud-based e-prescribing solutions. These focus on cost-effective, scalable platforms easily deployed in various healthcare settings.

For instance, in July 2024, Canada Health Infoway Inc. and Ava Industries Inc. partnered to integrate PrescribeIT, Canada's national e-prescribing service, into Ava Industries Inc.'s electronic medical record (EMR) system, benefiting over 1,000 prescribers. This integration will enable healthcare providers to send prescriptions directly to pharmacies, enhancing efficiency and patient outcomes. Ava's AI-driven tools and streamlined processes, combined with PrescribeIT, align to reduce administrative burdens and improve digital healthcare workflows. This collaboration advances both organizations' missions to enhance medication management and improve patient care.

Key Players Landscape and Outlook

The market for e-prescribing is segmented into products and services that are intended to increase the accuracy, efficiency, and accessibility of prescription management. In the service segment, the market is highly fragmented, with a huge number of local and global service providers offering comprehensive solutions. The new developments in e-prescribing in the market include the new product features and services that have been launched. As well as business strategic agreements involving mergers, acquisitions, and partnerships that help expand the market and enhance service integration.

For instance, the first electronic prescription service in Wales, England, was launched in the town of Rhyl, allowing general practitioners to send prescriptions securely to pharmacies and eliminating paper forms. This service improves efficiency, reduces environmental impact, and simplifies the prescription process. It is currently in live testing, with a full rollout across Wales that happened in January 2024.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global E-Prescribing Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Solutions
        • 4.2.1.1.1. Integrated Solutions
        • 4.2.1.1.2. Standalone Solutions
      • 4.2.1.2. Services
        • 4.2.1.2.1. Support
        • 4.2.1.2.2. Implementation
        • 4.2.1.2.3. Training
        • 4.2.1.2.4. Networks
    • 4.2.2. By Delivery Mode
      • 4.2.2.1. Web/Cloud-Based
      • 4.2.2.2. On-premises
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Pharmacies
      • 4.2.3.3. Office-Based Physicians
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product
    • 4.3.2. By Delivery Mode
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America E-Prescribing Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Solutions
        • 5.2.1.1.1. Integrated Solutions
        • 5.2.1.1.2. Standalone Solutions
      • 5.2.1.2. Services
        • 5.2.1.2.1. Support
        • 5.2.1.2.2. Implementation
        • 5.2.1.2.3. Training
        • 5.2.1.2.4. Networks
    • 5.2.2. By Delivery Mode
      • 5.2.2.1. Web/Cloud-Based
      • 5.2.2.2. On-Premises
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Pharmacies
      • 5.2.3.3. Office-Based Physicians
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States E-Prescribing Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Solutions
          • 5.3.1.2.1.1.1. Integrated Solutions
          • 5.3.1.2.1.1.2. Standalone Solutions
          • 5.3.1.2.1.2. Services
          • 5.3.1.2.1.2.1. Support
          • 5.3.1.2.1.2.2. Implementation
          • 5.3.1.2.1.2.3. Training
          • 5.3.1.2.1.2.4. Networks
        • 5.3.1.2.2. By Delivery Mode
          • 5.3.1.2.2.1. Web/Cloud-Based
          • 5.3.1.2.2.2. On-premises
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Hospitals
          • 5.3.1.2.3.2. Pharmacies
          • 5.3.1.2.3.3. Office-Based Physicians
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe E-Prescribing Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific E-Prescribing Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. Indonesia
  • 7.7. Philippines

8. South America E-Prescribing Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa E-Prescribing Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Approvals
  • 17.2. Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Practice Fusion, Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. McKesson Corporation
    • 20.3.3. Networking Technology, Inc. dba RXNT
    • 20.3.4. Athenahealth, Inc.
    • 20.3.5. EMDs, Inc. (CopuGroup Medical, Inc.)
    • 20.3.6. Cerner Corporation
    • 20.3.7. UnitedHealth Group
    • 20.3.8. Epic Systems Corporation
    • 20.3.9. NextGen Healthcare, Inc.
    • 20.3.10. DrFirst.com, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 3. Global E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 4. Global E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global E-Prescribing Market Share (%), By Region, 2018-2032F
  • Figure 6. North America E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 8. North America E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 9. North America E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 11. United States E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 13. United States E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 14. United States E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 17. Canada E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 18. Canada E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 21. Mexico E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 22. Mexico E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 25. Europe E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 26. Europe E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 30. Germany E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 31. Germany E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 32. France E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 34. France E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 35. France E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 38. Italy E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 39. Italy E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 42. United Kingdom E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 43. United Kingdom E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 46. Russia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 47. Russia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 50. Netherlands E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 51. Netherlands E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 54. Spain E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 55. Spain E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 58. Turkey E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 59. Turkey E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 62. Poland E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 63. Poland E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 66. South America E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 67. South America E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 71. Brazil E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 72. Brazil E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 75. Argentina E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 76. Argentina E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 79. Asia-Pacific E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 80. Asia-Pacific E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 82. India E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 84. India E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 85. India E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 86. China E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 88. China E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 89. China E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 92. Japan E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 93. Japan E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 96. Australia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 97. Australia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 100. Vietnam E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 101. Vietnam E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 104. South Korea E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 105. South Korea E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 108. Indonesia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 109. Indonesia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 112. Philippines E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 113. Philippines E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 116. Middle East & Africa E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 117. Middle East & Africa E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa E-Prescribing Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 121. Saudi Arabia E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 122. Saudi Arabia E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 125. UAE E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 126. UAE E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa E-Prescribing Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa E-Prescribing Market Share (%), By Product, 2018-2032F
  • Figure 129. South Africa E-Prescribing Market Share (%), By Delivery Mode, 2018-2032F
  • Figure 130. South Africa E-Prescribing Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Delivery Mode Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024